BiotechTube
Home/Cellastra/Henrik (Hank) Kulmala, PhD
H(

Henrik (Hank) Kulmala, PhD

EVP Regulatory/Product Development

Cellastra

Therapeutic Areas

Pulmonary FibrosisBurn InjuriesSurgical AdhesionsTraumatic Brain Injury

Cellastra Pipeline

DrugIndicationPhase
Anti-Scarring Gene Therapy PlatformPulmonary Fibrosis/Infections, Burn Injuries, Surgical Adhesions, Traumatic Brain InjuryPre-clinical

Leadership Team at Cellastra

KL
Karl L Mettinger, MD, PhD
Co-founder, Interim Chair, President & CEO
VK
Vinod Kumar, MD
EVP, Chief Medical Officer
View full Cellastra profile